Coherus Oncology Inc
Today
Company Overview
Key Metrics
Price Target & Forecast
Analyst Ratings
Recent News
About Coherus Oncology Inc (CHRS)
Coherus Oncology Inc trades under the ticker CHRS on NASDAQ NMS - GLOBAL MARKET and operates in the Biotechnology sector. Market capitalisation is around $211.67M. Over the past 52 weeks CHRS has traded between $1.09 and $2.62. This page pulls together CHRS's live quote, price history, key fundamentals and the EasyStox score so you can size up the company in one place.
CHRS scores 73 out of 100 on the EasyStox score, a grade of B. The score blends analyst ratings, news sentiment, fundamentals, momentum and valuation into a single number. Its strongest area is valuation, while price momentum drags the score down the most.
CHRS — frequently asked questions
What is the current CHRS price?
Coherus Oncology Inc last traded at $1.33, -6.99% on the day. Prices on this page refresh automatically during market hours.
What is CHRS's EasyStox score?
CHRS currently scores 73 out of 100 (grade B). The score combines analyst ratings, news sentiment, fundamentals, momentum and valuation. It is research help, not a recommendation to buy or sell.
Is CHRS a good investment?
EasyStox does not give buy or sell advice. What we can show you is the evidence: CHRS's score breakdown, its valuation and fundamentals, how analysts rate it, and how the price has moved. Read those together with your own goals and time horizon before deciding.
What is CHRS's P/E ratio?
CHRS trades on a price-to-earnings ratio of about 1.22. A higher P/E means investors are paying more for each dollar of earnings, usually because they expect growth.